Home » News » A Biotech CEO Sold His Company For $14 Billion And Shares The Best Career Advices

A Biotech CEO Sold His Company For $14 Billion And Shares The Best Career Advices

David Hung spent more than a decade in Silicon Valley while at the helm of a biotech company.



Hung’s the CEO of Axovant, a company that has a shot to launch the first new Alzheimer’s drug in 15 years. Before joining the company in April, Hung founded Medivation, a cancer drugmaker based San Francisco that Pfizer bought for $14 billion in August 2016.

Source

Leave a Reply

Your email address will not be published.